Treace Medical Concepts (TMCI) Total Current Liabilities (2020 - 2026)
Treace Medical Concepts' (TMCI) quarterly Total Current Liabilities came in at $34.5 million in Q1 2026, up 3.95% YoY from $33.2 million in Q1 2025, and up 12.59% on a QoQ basis from $30.6 million in Q4 2025.
Treace Medical Concepts (TMCI) Total Current Liabilities (2020 - 2026) Analysis & Trends
Treace Medical Concepts (TMCI) has 7 years of Total Current Liabilities data on file, last reported at $34.5 million in Q1 2026.
- Quarterly Total Current Liabilities rose 3.95% year-over-year to $34.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $34.5 million (up 3.95% YoY) and the FY2025 annual result came in at $30.6 million, down 12.28% from the prior year.
- Total Current Liabilities climbed to $34.5 million in Q1 2026, from $30.6 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $47.0 million in Q1 2024 to a low of $15.4 million in Q1 2022.
- A 5-year average of $33.1 million and a median of $33.2 million in 2025 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Current Liabilities soared 110.58% — and 2025, when it dropped 29.48%.
- Tracing TMCI's Total Current Liabilities over 5 years: stood at $30.2 million in 2022, then surged by 48.89% to $45.0 million in 2023, then declined by 22.45% to $34.9 million in 2024, then slipped by 12.28% to $30.6 million in 2025, then rose by 12.59% to $34.5 million in 2026.
- The last three Total Current Liabilities figures came in at $34.5 million (Q1 2026), $30.6 million (Q4 2025), and $40.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Treace Medical Concepts | 290.12 Mn | 244.50 Mn | 35.61 Mn | 41.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 41.50 Mn |
| Mar 31, 2026 | 34.49 Mn |
| Dec 31, 2025 | 30.64 Mn |
| Sep 30, 2025 | 40.91 Mn |
| Jun 30, 2025 | 41.90 Mn |
| Mar 31, 2025 | 33.18 Mn |
| Dec 31, 2024 | 34.93 Mn |
| Sep 30, 2024 | 38.26 Mn |
| Jun 30, 2024 | 44.45 Mn |
| Mar 31, 2024 | 47.05 Mn |
| Dec 31, 2023 | 45.03 Mn |
| Sep 30, 2023 | 33.15 Mn |
| Jun 30, 2023 | 30.02 Mn |
| Mar 31, 2023 | 23.30 Mn |
| Dec 31, 2022 | 30.25 Mn |
| Sep 30, 2022 | 22.58 Mn |
| Jun 30, 2022 | 16.64 Mn |
| Mar 31, 2022 | 15.38 Mn |
| Dec 31, 2021 | 18.21 Mn |
| Sep 30, 2021 | 10.72 Mn |